Vai ai contenuti. | Spostati sulla navigazione | Spostati sulla ricerca | Vai al menu | Contatti | Accessibilità

| Crea un account

Drago, Denise (2008) Experimental approaches for the pathogenic understanding of Alzheimer's disease. Effect of b-amyloid-metal ions complexes in in vitro and in vivo models. [Tesi di dottorato]

Full text disponibile come:

Documento PDF

Abstract (inglese)

Alzheimer's disease (AD) is classified as a conformational disease and is characterized by tissue insoluble deposits as a consequence of proteins aggregation. In AD brain, two different features of protein deposition are identified: intracellular neurofibrillary tangles and extracellular senile plaques. Several studies in literature paid attention to the main component of senile plaques: beta-amyloid peptide, which aggregates in various structures with the final formation of insoluble fibrils, typical of senile plaques. A huge number of reports indicate that, among putative aggravating factors, metal ions (Al, Zn, Cu, Fe) could specifically impair protein aggregation of Abeta and their oligomeric toxicity.The aim of this thesis is to investigate the effect of various Abeta-metal complexes, in comparison with Abeta alone, in various experimental models both in vitro and in vivo. The experimental approach is completely new with respect to other studies in literature where the Abeta and metal ions toxicity have been separately evaluated and not as a complex as Abeta-metals. This complex could better reproduce the same neuronal environmental condition as observed in the pathological events.

Statistiche Download - Aggiungi a RefWorks
Tipo di EPrint:Tesi di dottorato
Relatore:Folin, Marcella
Correlatore:Zatta, Paolo
Dottorato (corsi e scuole):Ciclo 20 > Scuole per il 20simo ciclo > BIOLOGIA E MEDICINA DELLA RIGENERAZIONE > INGEGNERIA DEI TESSUTI E DEI TRAPIANTI
Data di deposito della tesi:31 Gennaio 2008
Anno di Pubblicazione:31 Gennaio 2008
Parole chiave (italiano / inglese):Alzheimer's disease, amyloid, aggregation, metal ions.
Settori scientifico-disciplinari MIUR:Area 06 - Scienze mediche > MED/26 Neurologia
Struttura di riferimento:Dipartimenti > Dipartimento di Biologia
Codice ID:258
Depositato il:06 Nov 2008
Simple Metadata
Full Metadata
EndNote Format


I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

1. Abraham C. R., Selkoe D. J., Potter H. (1988) Immunochemical identification of the serine protease inhibitor a1-antichymotrypsin in the brain. Cell 52, 487-501. Cerca con Google

2. Abramov A. Y., Canevari L. & Duchen M. R. (2003) Changes in intra-cellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 23, 5088-5095. Cerca con Google

3. Adlerz L., Beckman M., Holdback S., Tehranian R., Cortés Toro V., Iverfeldt K. (2003) Accumulation of the amyloid precursor-like protein APLP2 and reduction of APLP1 in retinoic acid-differentiated human neuroblastoma cells upon curcumin-induced neurite retraction. Mol Brain Res 119, 62-72. Cerca con Google

4. Adlerz L., Holback S., Multhaup G., Iverfeldt K. (2007) IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways. J Biol Chem 282, 10203-9. Cerca con Google

5. Aleardi A. M., Benard G., Augereau O., Malgat M., Talbot J. C., Mazat J. P., Letellier T., Dachary-Prigent J., Solaini G. C., & Rossignol R. (2005) Gradual alteration of mitochondrial structure and function by ß-amyloids: Importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytocrome c release. J Bioenerg Biomembr 37, 207-225. Cerca con Google

6. Alfrey A. C. (1986) Aluminum metabolism. Kidney Int Suppl 18, S8-S11. Cerca con Google

7. Alfrey A. C., LeGrendre G. R., & Kaehny W. D. (1976) The dialysis encephalophaty syndrome. Possible aluminum intoxication. N Engl J Med 294, 184-188. Cerca con Google

8. Algotsson A. & Winblad B. (2007) The integrity of the blood-brain barrier in Alzheimer's disease. Acta Neurol Scand 115, 403-408. Cerca con Google

9. Allen D. D. & Yokel R. A. (1992) Dissimilar aluminum and gallium permeation of the blood-brain barrier demonstrated by in vivo microdialysis. J Neurochem 58, 903-908. Cerca con Google

10. Ambroggio E. E., Kim D. H., Separovic F., Barrow C. J., Barnham K. J., Bagatolli L. A., Fidelio G. D. (2005) Surface behaviour and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a mem-brane-disrupting peptide. Biophys J 88, 2706-2713. Cerca con Google

11. Amstrong R. A., Anderson J., Cowburn J. D., Cox J., Blair J. A. (1992) Aluminum administered in drinking water but not in diet influences biopterin metabolism in rodent. Biol Chem Hoppe Sey-ler 373, 1075-8. Cerca con Google

12. Anandatheerthavarada H. K., Biswas G., Robin M. A. & Avadhani N. G. (2003) Mitochondrial targeting and novel transmembrane ar-rest of Alzheimer's amyloid precursor rotein impairs mitochon-drial function in neuronal cells. J Cell Biol 161, 41-54. Cerca con Google

13. Andreasen N. & Blennow K., (2002) Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease. Pep-tides 23, 1205-1214. Cerca con Google

14. Anitha S., Shanmugavelu P., Gazula V. R., Shankar S. K., Menon R. B., Rao R. V. et al. (2002) Molecular understanding of aluminium bioinorganic chemistry in relevance to the pathology of Alz-heimer's disease. In: Group 12 Chemistry: From Fundamentals to Appilcations (ACS Symposium Series), American Chemical So-ciety, Washington, DC, vol. 822, pp. 228-245. Cerca con Google

15. Apelt J. & Schliebs R. (2001) Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res 894, 21-30 Cerca con Google

16. Arispe N., Pollard H. B. & Rojas E. (1994) ß-amyloid Ca2+ channel hy-pothesis for neuronal death in Alzheimer's disease. Mol Cell Bio-chem 140, 119-125. Cerca con Google

17. Arundine M. & Tymianski M. (2003) Molecular mechanisms of cal-cium-dependent neurodegeneration in excitotoxicity. Cell Cal-cium 34, 325-337. Cerca con Google

18. Asami-Odaka A., Ishibashi Y., Kikuchi T., Kitada C. & Suzuki N. (1995) Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 34, 10272-10278. Cerca con Google

19. Assaf S. Y. & Chung S. H. (1984) Release of endogenous Zn2+ from brain tissue during activity. Nature 308, 734-736. Cerca con Google

20. Atwood C. S., Moir R. D., Huang X., Scarpa R. C., Bacarra N. M., Romano D. M., Hartshorn M. A., Tanzi R. E., Bush A. I. (1998) Dramatic aggregation of Alzheimer abeta by Cu (II) is induced by conditions representing physiological acidosis. J Biol Chem 273, 12817-26. Cerca con Google

21. Atwood C. S., Obrenovich M. E., Liu T., Chan H., Perry G., Smith M. A., Martins R. N. (2003) Amyloid-ß: a chameleon walking in two worlds: a reviw of the trophic and toxic properties of amyloid-ß Brain Res Rev 43, 1-16. Cerca con Google

22. Atwood C. S., Scarpa R. C., Huang X., Moir R. D., Jones W. D., Fairlie D. P., Tanzi R. E., Bush A. I. (2000) Characterization of copper interactions with Alzheimer amyloid beta peptides identification of an attomolar-affinity copper binding site on amyloid beta 1-42. J Neurochem 75, 1219-33. Cerca con Google

23. Audus K. L., Holthaus S. R., Van Bree J. B. M. M., Shinogle J. A., (1988) Aluminum effects on growth of brain microvessel endothe-lial cells in primary culture. Res Commun Chem Pathol Pharmacol 60, 71-85. Cerca con Google

24. Avdulov N. A., Chochina S. V., Igbavboa U., Warden C. S, Vassiliev A. V., Wood W. G. (1997) Lipid binding to amyloid beta-peptide ag-gregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J Neurochem 69, 1746-52. Cerca con Google

25. Avila J. (2006) Tau phosphorylation and aggregation in Alzheimer's disease pathology. FEBS Lett 580, 2922-7. Cerca con Google

26. Awasthi A., Matsunaga Y., Yamada T. (2005) Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides. Experimental Neurology 196, 282-289. Cerca con Google

27. Bading J. R., Yamada S., Mackic J. B., Kirkman L., Miller C., Calero M., Ghiso J., Frangione B., Zlokovic B. V. (2002) Brain clearance of Alzheimer's amyloid-ß40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy. J Drug Target 10, 359-368. Cerca con Google

28. Bagnoli S., Cellini E., Tedde A., Nacmias B., Piacentini S., Bessi V., Bracco L., Sorbi S. (2007) Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Neurosci Lett 418, 262-5. Cerca con Google

29. Baiguera S., Conconi M. T. Guidolin D., Mazzocchi L. K., Malen-dowicz L. K., Parnigotto P. P., Spiazzi R., Nussdorfer G. G. (2004) Ghrelin inhibits in vitro angiogenic activity of rat brain microvas-cular endothelial cells. Int J Mol Med 14, 849-854. Cerca con Google

30. Bala Gupta V., Anitha S.,. Hedge M. L, Zecca L., Garruto M. R., Ravid R., Shankar, S. K., Stein R., Shanmugavelu P., Jagannatha Rao K. S. (2005) Aluminium in Alzheimer’s disease: are we still at a crossroad?. Cell Mol Life Sci 62, 143-158. Cerca con Google

31. Banks W. A., Banks A. J., Zatta P. (1995) The blood brain-barrier in aluminum toxicity and Alzheimer's disease, in: Non-neuronal Cells in Alzheimer’s disease, Zatta P. & Nicolini M. (Eds), World Scientific, Singapore, pp. 1-12. Cerca con Google

32. Banks W. A., Fasold M. B., Kastin A. J. (1997a) Measurements of ef-flux rate from brain to blood. In : Irvine G. B., Williams C. H. (Eds.), Methods in Molecular Biology: Neuropeptides Protocols. Humana Press, Totowa, N. J., pp. 353-360. Cerca con Google

33. Banks W. A., Kastin A. J., Maness L. M., Banks M. F., Shayo M., McLay R. N. (1997b) Interactions of ß-amyloids with the blood-brain barrier. Ann NY Acad Sci 826, 190-9. Cerca con Google

34. Banks W. A., Maness L. M., Banks M. F., Kastin A. J. (1996) Alumi-num-sensitive degradation of amyloid β-protein1-40 by murine and human intracellular enzymes. Neurotoxicol Teratol 18, 671-677. Cerca con Google

35. Banks W. A., Robinson S. M., Verma S., Morley J. E. (2003) Efflux of human and mouse amyloid ß proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease. Neurosci-ence 121, 487-492. Cerca con Google

36. Banks W. A., Niehoff M. L., Drago D., Zatta P. (2006) Aluminum com-plexing enhances amyloid beta protein penetration of blood-brain barrier. Brain Res 1116, 215-221. Cerca con Google

37. Bathia R., Lin H. & Lai R. (2000) Fresh and globular amyloid ß pro-tein (1-42) induces rapid cellular degeneration: evidence for AßP channel-mediated cellular toxicity. FASEB J 14, 1233-1243. Cerca con Google

38. Bayer T. A., Paliga K., Weggen S., Wiestler O. D., Beyreuther K., Multhaup G. (1997) Amyloid precursor-like protein 1 accumu-lates in neuritic plaques in Alzheimer's disease. Acta Neuropathol (Berl) 94, 519-24. Cerca con Google

39. Beauchemin D. & Kisilevsky R. (1998) A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques. Anal Chem 70, 1026-1029. Cerca con Google

40. Bellingham S. A., Ciccotosto G. D., Needham B. E., Fodero L. R., White A. R., Masters C. L., Cappai R., Camakaris J. (2004a) Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embrionic fibroblasts. J Neurochem 91, 423-428. Cerca con Google

41. Bellingham S. A., Lahiri D. K., Maloney B., La Fontaine S., Multaup G., Camakaris J. (2004b) Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene. J Biol Chem 279, 20378-20386. Cerca con Google

42. Bernardi P., Krauskopf A., Basso E., Petronilli V., Blachly-Dyson E., Di Lisa F., Forte M. A. (2006) The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 273, 2077-2099. Cerca con Google

43. Bernardi P., Petronilli V., Di Lisa F., Forte M. (2001) A miotochondrial perspective on cell death. Trends Biochem Sci 26, 112-127. Cerca con Google

44. Berridge M. V. & Tan A. S. (1993) Characterization of the cellular re-duction of 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheniltetrazolium bromide (MTT): subcellular localization, substate dependence, and involment of mitochondrial electron transport in MTT reduc-tion. Arch Biochem Biophys 303, 474-482. Cerca con Google

45. Bertram L., McQueen M. B., Mullin K., Blacker D., Tanzi R. E. (2007) Systematic meta-analyses of Alzheimer disease genetic associa-tion studies: the AlzGene database. Nat Genet 39, 17-23 Cerca con Google

46. Billings L. M., Oddo S., Green K. N., McGaugh J. L., LaFerla F. M. (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688. Cerca con Google

47. Bitan G., Kirkitadze M. D., Lomakin A., Vollers S. S., Benedek G. B., Teplow D. B. (2003) Amyloid ß-protein (Aß assembly: Aß40 and Aß42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100, 330-335. Cerca con Google

48. Bitan G., Lomakin A., Teplow D. B. (2001) Amyloid beta protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. J Biol Chem 276, 35176-35184. Cerca con Google

49. Blass J. P. (2003) Cerebrometabolic abnormalities in Alzheimer's dis-ease. Neurol Res 25, 556-566. Cerca con Google

50. Blurton-Jones M. & LaFerla F. M. (2006) Pathways by which Abeta facilitates tau pathology. Curr Alzheimer Res 3, 437-48. Cerca con Google

51. Bogdanovic N., Bretillon L., Lund E. G., Diczfalusy U., Lannfelt L., Winblad B., Russell D. W., Bjorkhem I. (2001) On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci Lett 314, 45-48. Cerca con Google

52. Bordelon J. R., Smith Y., Nairn A. C., Colbran R. J., Greengard P., Muly E. C. (2005) Differential localization of protein phos-phatase-1alpha, beta and gamma1 isoforms in primate prefron-tal cortex. Cereb Cortex Dec 15, 1928-37. Cerca con Google

53. Bosetti F., Brizzi F., Barogi S., Mancuso M., Sicilano G., Tendi E. A., Murri L., Rapoport S. I. & Solaini G. (2002) Cytocrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in plate-lets and brain from patients with Alzheimer disease. Neurobiol Aging 23, 371-376. Cerca con Google

54. Boyd-Kimball D., Sultana R., Mohmmad-Abdul H., Butterfield D. A., (2004) Rodent Aß(1-42) exhibits oxidative stress properties simi-lar to those of human Aß(1-42): implications for proposed mechanisms of toxicity, J Alzheimer Dis 6, 515-525. Cerca con Google

55. Braak H. & Braak E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259. Cerca con Google

56. Bressler J. P., Olivi L., Cheong J. H., Kim J., Maerten A., Bannon D. (2007) Metal transporters in intestine and brain: their involve-ment in metal-associated neurotoxicities. Hum Exp Toxicol 26, 221-9. Cerca con Google

57. Breteler M. M. (2000) Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 21, 153-160. Cerca con Google

58. Brookes P. S., Yoon Y., Robotham J. L., Anders M. W., Sheu S. S. (2004) Calcium, ATP, and ROS: a mitochondrial love-hate trian-gle. Am J Physiol Cell Physiol 287, C817-33. Cerca con Google

59. Brustovetsky N., LaFrance R., Purl K. J., Brustovetsky T., Keene C. D., Low W. C., Dubinsky J. M. (2005) Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's disease. J Neurochem 93, 1361-1370. Cerca con Google

60. Bu G., Cam J., Zerbinatti C. (2006) LRP in amyloid-ß production and metabolism. Ann NY Acad Sci 1086, 35-53. Cerca con Google

61. Buee L., Hof P. R., Delacourte A. (1997) Brain microvascular changes in Alzheimer's disease and other dementias. Ann NY Acad Sci 826, 7-24. Cerca con Google

62. Burton A. (2006) Inhibition of butyrylcholinesterase could ease AD. Lancet Neurol. 5, 27. Cerca con Google

63. Busciglio J., Lorenzo A., Yeh J. & Yankner B.A. (1995) beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888. Cerca con Google

64. Bush A. I. (2003) The metallobiology of Alzheimer's disease. Trends Neurosci 26, 207-214. Cerca con Google

65. Bush A. I. & Tanzi R. E. (2006) The galvanization of beta-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 99, 7179-7317 Cerca con Google

66. Butterfield D. A. & Lauderback C. M. (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential cause and consequences involving amyloid ß-peptide associated free radical oxidative stress. Free Radic Biol Med 32, 1050-1060. Cerca con Google

67. Buxbaum J. D., Liu K. N., Luo Y., Slack J. L., Stocking K. L., Peschon J. J. Johnson R. S., Castner B. J., Ceretti D. P. Black R. A. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273, 27765-27767. Cerca con Google

68. Buxbaum J. D., Ruelfi A. A., Parker C. A., Cypess A. M. & Greengard P. (1994) Cacium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-indipendent manner. Proc Natl Sci USA 91, 4489-4493. Cerca con Google

69. Campbell A., Becaria A., Lahiri D. K., Sharman K., Bondy S. C. (2004) Chronic exposure to Al in drinking water increases in-flammatory parameters selectively in the brain. J Neurosci Res 75, 565-572. Cerca con Google

70. Campbell A., Smith M. A., Sayre L. M., Bondy S. C., Perry G. (2001) Mechanisms by which metals promote events connected to neu-rodegenerative diseases. Brain Res Bull 55, 125-132. Cerca con Google

71. Candy J. M., Klinowski J., Perry R. H., Perry E. K., Fairbairn A., Oak-ley A. E. (1986) Aluminosilicates and senile plaque formation in Alzheimer’s disease. Lancet 1, 354-357. Cerca con Google

72. Canevari L., Abramov A. Y. & Duchen M. R. (2004) Toxicity of amyloid ß peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem Res 29, 637-650. Cerca con Google

73. Canevari L., Clark J. B., Bates, T. E. (1999) ß-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mito-chondria. FEBS Lett 457, 131-134. Cerca con Google

74. Casley C., Canevari L., Land J., Clark J. & Sharpe M. (2002) ß-amyloid inhibits mitochondrial respiration and key enzyme ac-tivities. J Neurochem 80, 91-100. Cerca con Google

75. Caspersen C., Wang N., Yao J., Sosunov A., Chen X., Lustbader J. W., Xu H. W., Stern D., Mckhann G. & Yan S. D. (2005) Mito-chondrial Aß: a potential role point for neuronal metabolic dys-function in Alzheimer's disease. FASEB J 19, 2040-2041. Cerca con Google

76. Chafi A. H., Hauw J. J., Rancurel G., Berry J. P., Galle C. (1991) Absence of aluminum in Alzheimer's disease brain tissue: electron microprobe and ion microprobe studies. Neurosci Lett 123, 61-4. Cerca con Google

77. Chagnon P., Betard C., Robitaille Y., Cholette A. & Gauvreau D. (1995) Distribution of brain cytocrome oxidase activity in various neurodegenerative diseases. Neuroreport 6, 711-715. Cerca con Google

78. Chen M. & Cook K. D. (2007) Oxidation artifacts in the electrospray mass spectrometry of Abeta Peptide. Anal Chem 79, 2031-2036. Cerca con Google

79. Chen Y. R. & Glabe C. (2006) Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Aß40 and Aß42: stable trimer or tetramer formation by Aß42. J Biol Chem 281, 24414-24422. Cerca con Google

80. Cherny R. A., Atwood C. S., Xilinas M. E., Gray D. N., Jones W. D., McLean C. A., Barnham K. J., Volitakis I. et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer‘s disease transgenic mice. Neuron 30, 665-76. Cerca con Google

81. Cherny R. A., Legg J. T., Mclean C. A., Fairlie D. P., Huang X., At-wood S. C., Beyrauther K., Tanzi R. E., Masters C.L. Bush A. I. (1999) Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J Biol Chem 274, 23223-23228. Cerca con Google

82. Chiti F., Stefani M., Taddei N., Ramponi G., Dobson C. M. (2003) Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424, 805-808. Cerca con Google

83. Chui D. H., Tanahashi H., Ozawa K., Ikeda S., Checler F., Ueda O., Suzuki H., Araki W., Inoue H., Shirotani K., Takahashi K., Gallyas F., Tabira T. (1999) Transgenic mice with Alzheimer presenilin 1 mutation show accelerated neurodegeneration without amyloid plaque formation. Nat Med 5, 560-4. Cerca con Google

84. Cirrito J. R., Deane R., Fagan A. M., Spinner M. L., Parsadanian M., Finn M. B., Jiang H. et al. (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-ß deposition in an Alz-heimer disease mouse model. J Clin Invest 115, 3285-90. Cerca con Google

85. Cleary J. P., Walsh D. M., Hofmeister J. J., Shankar G. M., Kuskowski M. A., Selkoe D. J. & Ashe K. H. (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8, 79-84. Cerca con Google

86. Clifford P. M., Zarrabi S., Siu G., Kinsler K. J., Kosciuk M. C., Venkataraman V., D’Andrea M. R., Dinsmore S., Nagele R. G. (2007) Aß peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res 1142, 223-236. Cerca con Google

87. Conconi M. T., Lora S., Baiguera S., Boscolo E., Folin M., Scienza R., Rebuffat P., Parnigotto P. P., Nussdorfer G. G. (2004) In vitro cul-ture of rat neuromicrovascular endothelial cells on polymeric scaffolds. J Biomed Mater Res 71, 669-674. Cerca con Google

88. Connor J. R., Milward E. A., Moalem S., Sampietro M., Boyer P., Percy M. E., Vergani C., Scott R. J. & Chorney M. (2001) Is hemochromatosis a risk factor for Alzheimer’s disease? J Alzheimer Dis 3, 471-477. Cerca con Google

89. Crapper D. R., Krishnan S. S. & Dalton A. J. (1973) Brain aluminum distribution in Alzheimer’s disease and experimental neurofibrillary degeneration. Science 180, 511-513. Cerca con Google

90. Cricthon R. R., Florence A., Ward R. J. (2002) Aluminum and iron in the brain-prospects for chelation. Coord Chem Rev 228, 365-371. Cerca con Google

91. Cuajungco M. P., Goldstein L. E., Nunomura A., Smith M. A., Lim T. J., Atwood C. S., Huang X., Farrag Y. W. et al. (2000) Evidence that the beta-amyloid plaques of Alzheimer’s disease represent the redox-silencing and entombment of abeta by zinc. J Biol Chem 275, 19439-19442. Cerca con Google

92. Curtain C. C., Ali F. E., Smith D. G., Bush A. I., Masters C. L., Barnham K. J. (2003) Metal ions, pH, and cholesterol regulate the interactions of Alzheimer’s disease amyloid-beta peptide with membrane lipid. J Biol Chem 278, 2977-2982. Cerca con Google

93. Curtain C. C., Ali F., Volitakis I., Cherny R. A., Norton R. S., Beyreuther K., Barrow C. J., Masters C. L. et al. (2001) Alz-heimer’s disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure con-taining superoxidase dismutase-like subunits. J Biol Chem 276, 20466-20473. Cerca con Google

94. Dahlgren K. N., Manelli A. M., Stine W. B. Jr, Baker L. K., Krafft G. A. & LaDu M. J. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277, 32046-32053. Cerca con Google

95. Datki Z., Juhasz A., Galfi M., Soos K., Papp R., Zadori D., Penke B. (2003) Method for measuring neurotoxicity of aggregating poly-peptides with the MTT assay on differentiated neuroblastoma cells. Brain Res Bull 62, 223-229. Cerca con Google

96. Daydé S., Brumas V., Champmartin D., Rubini P., Berthon G. (2003) Aluminum speciation studies in biological fluids. Part 9. A quan-titative investigation of aluminum(III)-glutamate complex equilib-ria and their potential implications for aluminum metabolism and toxicity. J. Inorg Biochem 97, 104-117. Cerca con Google

97. De Jong F. J., Peeters R. P., den Heijer T., van der Deure W. M., Hof-man A., Uitterlinden A. G., Visser T. J., Breteler M. M. (2007) The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 92, 636-40. Cerca con Google

98. De la Torre J. C. (1997) Hemodynamic consequences of deformed mi-crovessels in the brain in Alzheimer's disease. Ann NY Acad Sci 826, 75-91. Cerca con Google

99. De la Torre, J. C. (2004) Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neu-rol 3, 184-190. Cerca con Google

100. Deane R. & Zlokovic B. V. (2007) Role of the blood-barrier in the pathogenesis of Alzheimer’s disease. Curr Alzheimer Res 4, 191-7. Cerca con Google

101. Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., Xu F., Parisi M., LaRue B., Hu H.W., Spijkers P., Guo H., Song X., Len-ting P. J., Van Nostrand W. E., Zlokovic B. V. (2004) LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43, 333-344. Cerca con Google

102. Deane R., Yan S. D., Submamaryan R. K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L. et al. (2003) RAGE mediates amy-loid-ß peptide transport permeation of the blood-brain barrier demonstrated by in vivo across the blood-brain barrier and ac-cumulation in brain. Nat Med 7, 907-913. Cerca con Google

103. Deloncle R. & Guillard O. (1990) Mechanism of Alzheimer's disease: arguments for a neurotransmitter-aluminium complex implica-tion. Neurochem Res 15, 1239-1245. Cerca con Google

104. Demeester N., Baier G., Enzinger C., Goethals M., Vandekerckhove J., Rosseneu M. & Labeur C. (2000) Apoptosis induced in neu-ronal cells by C-terminal amyloid ß-fragments is correlated with their aggregation properties in phospholipids membranes. Mol Membr Biol 17, 219-228. Cerca con Google

105. Demuro A., Mina E., Kayed R., Milton S. C., Parker I. & Glabe C. G. (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280, 17294-17300. Cerca con Google

106. Deshpande A., Mina E., Glabe C. G., Busciglio J. (2006) Different conformations of amyloid ß induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26, 6011-6018. Cerca con Google

107. Dickson D. W., Crystal H. A., Bevona C., Honer W., Vincent I., Davies P. (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16, 285-298. Cerca con Google

108. Dickson D. W. (1997) Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies. Neurobiol Aging 18, S21-26. Cerca con Google

109. Diez M., Danner S., Frey P., Sommer B., Staufenbiel M., Wiederhold K. H., Hokfelt T. (2003) Neuropeptide alterations in the hippo-campal formation and cortex of transgenic mice overexpessing beta-amyloid precursor protein (APP) with Swedish double muta-tion (APP23). Neurobiol Dis 14, 579-94. Cerca con Google

110. Dobson C. M. (2001) The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci 356, 133-145. Cerca con Google

111. Dobson C. M. (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24, 329-332. Cerca con Google

112. Dobson C. M. (2004) Experimental investigation of protein folding and Misfolding. Methods 34, 4-14. Cerca con Google

113. Dodart J. C., Meziane H., Mathis C., Bales K. R., Paul S. M. & Ungerer A. (1999) Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav Neurosci 113, 982-990. Cerca con Google

114. Domingo J. L. (2006) Aluminum and other metals in Alzheimer’s dis-ease: a review of potential therapy with chelating agents. J Alz-heimer Dis 10, 331-341. Cerca con Google

115. Dong J., Atwood C. S., Anderson V. E., Siedlak S. L., Smith M. A., Perry G., Carey P. R. (2003) Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochem 42, 2768-2773. Cerca con Google

116. Drago D., Bettella M., Bolognin S., Cendron L., Scancar J., Milacic R., Ricchelli F., Casini A., Messori L., Tognon G., Zatta P. (2007b) Potential pathogenic role of ß-amyloid1-42-aluminum complex in Alzheimer’s disease Int J Biochem Cell Biol, in press (doi:10.1016/j.biocel.2007.10.014). Cerca con Google

117. Drago D., Fincati K., Valenti M., Dalle Carbonare L., Dal Martello C., Olivato I., Zatta P. Potential pathogenic role of ß-amyloid metal complexes on neuroblastoma cells: Microarray and Real time analysis on gene expression profile. Manuscript submitted. Cerca con Google

118. Drago D., Folin M., Baiguera S., Tognon G., Ricchelli F., P. Zatta (2007a) Comparative effects of Aß(1-42)-Al complex from rat and human on rat endothelial cells. J Alzheimers Dis 11, 33-44. Cerca con Google

119. Drago D., Sensi S., Ricchelli F., Cavaliere A., Zatta P. Alterations of neuronal calcium homeostasis and mitochondria function by ß-amyloid1-42-aluminum complex. Manuscript submitted. Cerca con Google

120. Dyrks T., Dyrks E., Masters C.L. & Beyreuther K. (1993) Amyloidogenicity of rodent and human beta A4 sequences. FEBS Lett 324, 231-236. Cerca con Google

121. Edwardson J. A., Candy J. M., Ince P. G., McArthur F. K., Morris C. M., Oakley A. E., Taylor G. A., Bjertness E. (1992) Aluminium accumulation, beta-amyloid deposition and neurofibrillary changes in the central nervous system. Ciba Found Symp 169, 165-79. Cerca con Google

122. Ehmann W. D., Markesbery W. R., Alauddin M., Hossain T. I. M. & Brubaker E. H. (1986) Brain trace elements in Alzheimer’s dis-ease. Neurotoxicology 7, 195-206. Cerca con Google

123. Esiri M. M., Nagy Z., Smith M. Z., Barnetson L., Smith A. D. (1999) Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354, 919-920. Cerca con Google

124. Evans P. & Harrington C. (1998) Aluminosilicate particulate and beta-amyloid in vitro interactions: a model of Alzheimer plaque formation. Biochem Soc Trans 26, S251. Cerca con Google

125. Exley C. (1999) A molecular mechanism of aluminium-induced Alz-heimer’s disease ? J Inorg Biochem 76, 133-140. Cerca con Google

126. Favarato M., Zanoni S., Nicolini M. & Zatta P. (1994) Histofluorimetric aluminum determination in the core of senile plaques from Alzheimer’s disease. Life Chem 11, 71-78. Cerca con Google

127. Favarato M., Zatta P., Perazzolo M., Fontana L., Nicolini M. (1992) A-luminum(III) influences the permeability of the blood-brain bar-rier to [14C]sucrose in rats. Brain Res 569, 330-335. Cerca con Google

128. Fernandez-Vizarra P., Fernandez A. P., Castro-Blanco S., Serrano J., Bentura M. L., Martinez-Murillo R., Martinez A. & Rodrigo J. (2004) Intra- and extracellular Abeta and PHF in clinically evalu-ated cases of Alzheimer’s disease. Histol Histopathol 19, 823-844. Cerca con Google

129. Ferreiro E., Oliveira C. R., Pereira C. (2004) Involvement of endo-plasmic reticulum Ca2+ release through ryanodine and inositol 1,4,5-triphosphate receptors in the neurotoxic effects induced by the amyloid-beta peptide. J Neurosci Res 76, 872-880. Cerca con Google

130. Folin M., Baiguera S., Tommasini M., Guidolin D., Conconi M. T., De Carlo E., Parnigotto P. P., Nussdorfer G. G. (2005) Effects of ß-Amyloid on rat neuromicrovascular endothelial cells cultured in vitro. Int J Mol Med 15, 929-935. Cerca con Google

131. Fonfria E., Marshall I. C., Boyfield I., Skaper S. D., Hughes J. P., Owen D. E., Zhang W., Miller B. A., Benham C. D., McNulty S., (2005) Amyloid beta-peptide (1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J Neurochem 95, 715-723. Cerca con Google

132. Fraga C. G., Oteiza P. I., Golub M. S., Gershwin M. E., Keen C. L. (1990) Effects of aluminum on brain lipid peroxidation. Toxicol Lett 51, 213-9. Cerca con Google

133. Francis Y. I., Dis J. K., Kariti M., Stephanou A., Latchman D. S., (2007) p300 activation by Presenilin 1 but not by its M146L mu-tant. Neurosci Lett 413, 137-40. Cerca con Google

134. Frederickson C. J. & Bush A. I. (2001) Synaptically released zinc: physiological functions and pathological effects. Biometals 14, 353-366. Cerca con Google

135. Gamerdinger M., Clement A. B., Behl C. (2007) Cholesterol like ef-fects of selective cyclooxygenase inhibitors and fibrates on cellu-lar membranes and amyloid-ß production. Mol Pharmacol 72, 141-151. Cerca con Google

136. Gandolfi L., Stella M. P., Zambenedetti P., Zatta P. (1998) Aluminum alters intracellular calcium homeostasis in vitro. Biochim Biophys Acta 1406, 315-320. Cerca con Google

137. Georganopoulou D. G., Chang L., Nam J. M., Thaxton C. S., Mufson E. J., Klein W. L., Mirkin C. A. (2005) Nanoparticle-based detec-tion in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer’s disease. Proc Natl Acad Sci USA 102, 2273-2276. Cerca con Google

138. Gerhart D. Z., Enerson B. E., Zhdankina O. Y., Leino R. L., & Drenes L. R. (1997) Expression of monocarboxylate transporter MTC 1 by brain endothelium and glia in adult and suckling rats. Am J Physiol 273, E207-213. Cerca con Google

139. Ghersi-Egea J. F., Gorevic P. D., Ghiso J., Frangione B., Patlak C. S., Fenstermacher J. D. (1996) Fate of cerebrospinal fluid-borne amyloid ß-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J Neurochem 67, 880-883. Cerca con Google

140. Ghribi O., DeWitt D. A., Forbes M. S., Herman M. M. & Savory J. (2001) Coinvolvement of mitochondria and endoplasmic reticu-lum in regulation of apoptosis: changesin cytochrome c, Bcl-2 and Bax in the hippocampus of aluminium-treated rabbits. Brain Res 903, 66-73. Cerca con Google

141. Gilman S., Koeppe R.A., Little R., An H., Junck L., Giordani B., Per-sad C., Heumann M., Wernette K. (2004) Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease. Ann Neurol 55, 774-780. Cerca con Google

142. Glabe C. G. (2001) Intracellular mechanism of amyloid accumulation and pathogenesis in Alzheimer’s disease. J Mol Neurosci 17, 137-145. Cerca con Google

143. Glabe C. G. (2004) Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem Sci 29, 542-547. Cerca con Google

144. Glabe C. G. (2006) Common mechanisms of amyloid oligomers pathogenesis in degenerative disease. Neurobiol Aging 27, 570-575. Cerca con Google

145. Gloor S. M., Wachtel M., Bollinger M. F., Ishihara H., Landmann R., Frei K. (2001) Molecular and cellular permeability control at the blood-brain barrier. Brain Res Brain Res Rev 36, 258-264. Cerca con Google

146. Glowinski J. & Iversen L. L. (1966) Regional studies of catechola-mines in the rat brain: I. The disposition of [3H] norepinephrine, [3H] dopamine and [3H] dopa in various regions of the brain. J Neurochem 13, 655-669. Cerca con Google

147. Gong Y., Chang L., Viola K. L., Lacor P. N., Lambert M. P., Finch C. E., Krafft G. A., Klein W. L. (2003) Alzheimer’s disease-affected brain: Presence of oligomeric Aß ligands (ADDLs) suggests a mo-lecular basis for reversible memory loss. Proc Natl Acad Sci USA 100, 10417-22. Cerca con Google

148. Good P. F., Perl D. P., Bierer L. M., Schmeidler J. (1992) Selective ac-cumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer’s disease: laser microprobe (LAMMA) study. Ann Neurol 31, 286-92. Cerca con Google

149. Goodman Y. & Mattson M. P. (1994) Secreted forms of ß-amyloid pre-cursor protein protect hippocampal neurons against amyloid ß-peptide-induced oxidative injury. Exp Neurol 128, 1-12. Cerca con Google

150. Goto J. J. & Tanzi R. E. (2002) The role of the low-density lipoprotein receptor-related protein (LRP1) in Alzheimer's Abeta generation: development of a cell-based model system. J Mol Neurosci 19, 37-41. Cerca con Google

151. Grace E. A. & Busciglio J. (2003) Aberrant activation of focal adhesion proteins mediates fibrillar amyloid ßï€ºï€ implications for Alzheimer’s disease. Neurosci 114, 265-273. Cerca con Google

152. Grace E. A., Rabiner C. A. & Busciglio J. (2002) Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience 114, 265-273. Cerca con Google

153. Grammas P., Yamada M., Zlokovic B. V. (2002) The cerebromicrovas-culature: a key player in the pathogenesis of Alzheimer's disease, J Alzheimer Dis 4, 217-223. Cerca con Google

154. Greenblatt D. J. & Koch-Weser J. (1975) Clinical pharmacokinetics. N Engl J Med 293, 702-705. Cerca con Google

155. Groner E., Ashani Y., Schorer-Apelbaum D., Sterling J., Herzig Y., Weinstock M. (2007) The kinetics of inhibition of human acetyl-cholinesterase and butyrylcholinesterase by two series of novel carbamates. Mol Pharmacol 71, 1610-7. Cerca con Google

156. Grundke-Iqbal I., Fleming J., Tung Y. C., Lassmann H., Iqbal K., Joshi J. G. (1990) Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (Berl) 81, 105-110. Cerca con Google

157. Guidolin D., Vacca A., Nussdorfer G., Ribatti D. (2004) A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Ma-trigel assay in vitro. Microvasc Res 67, 117-124. Cerca con Google

158. Gunter T., Buntinas L., Sparagna G., Eliseev R., Gunter K. (2000) Mitochondrial calcium transport: mechanism and functions. Cell Calcium 28, 285-296. Cerca con Google

159. Guo Q., Robinson N. & Mattson M. P. (1998) Secreted ß-amyloid pre-cursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kB and stabilization of calcium homeostasis. J Biol Chem 273, 12341-12351. Cerca con Google

160. Gutteridge J. M. C., Quinlan G. J., Clark I., Halliwell B. (1985) Alu-minium salts accelerate peroxidation of membrane lipids stimu-lated by iron salts. Biochem Biophys Acta 835, 441-447. Cerca con Google

161. Gyure K. A., Duhram R., Stewart W. F., Smialek J. E., Troncoso J. C. (2001) Intraneuronal Aß-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 125, 489-492. Cerca con Google

162. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B. & Selkoe D. J. (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325. Cerca con Google

163. Hardy J. & Gwinn-Hardy K. (1998) Genetic classification of primary neurodegenerative disease. Science 282, 1075-1079. Cerca con Google

164. Hardy J. & Higgins G. A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185. Cerca con Google

165. Hardy J. & Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353-356. Cerca con Google

166. Harper J. D., Wong S. S., Lieber C. M., Lansbury P. T. (1997) Observation of metastable Aß amyloid protofibrils by atomic force microscopy. Chem Biol 4, 119-125. Cerca con Google

167. Harris-White M. E. & Frautschy S. A. (2005) Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition. Curr Drug Targets CNS Neurol Disord 4, 469-80. Cerca con Google

168. Hartley D. M., Walsh D. M., Ye C. P., Diehl T., Vasquez S., Vassilev P. M., Teplow D. B. & Selkoe D. J. (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19, 8876-8884. Cerca con Google

169. Hashimoto M., Rockenstein E., Crews L., Masliah E. (2003) Role of protein aggregation in mitochondrial dysfunction and neurode-generation in Alzheimer’s and Parkinson’s diseases. Neuromol Med 4, 21-36. Cerca con Google

170. Hauptmann S., Keil U., Scherping I., Bonert A., Eckert A., Muller W. E. (2006) Mitochondrial dysfunction in sporadic and genetic Alz-heimer’s disease. Exp Gerontol 41, 668-73. Cerca con Google

171. Head E., Azizeh B. Y., Lott I. T., Tenner A. J., Cotman C. W., Cribbs D. H. (2001) Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down syndrome. Neurobiol Dis 8, 252. Cerca con Google

172. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A. & Butterfield D. A. (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A 91, 3270-3274. Cerca con Google

173. Heutink P. (2000) Untangling tau-related dementia. Hum Mol Genet 9, 979-986. Cerca con Google

174. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R. L., Atwood C. S., Johnson A. B., Kress Y. et al. (2001) Mitochondrial Abnor-malities in Alzheimer’s disease. J Neurosci 21, 3017-3023. Cerca con Google

175. Hoerndli F. J., Toigo M., Schild A., Gotz J., Day P. J. (2004) Reference genes identified in SH-SY5Y cells using custom-made gene ar-rays with validation by quantitative polymerase chain reaction. Anal Biochem 335, 30-41. Cerca con Google

176. Holsinger R. M., Lee J. S., Boyd A., Masters C. L., Collins S. J. (2006) CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias. Neurology 67, 710-2. Cerca con Google

177. Hou L. M., Shao H. Y., Zhang Y. B., Li H., Menon N. K., Neuhaus E. B., Brewer J. M., Byeon I. J. L. et al. (2004) Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the met35 oxidation state affects the mechanism of the amyloid formation. J Am Chem Soc 126, 1992-2005. Cerca con Google

178. House E., Collingwod J., Khan A., Korchazkina O., Berthon G. & Exley C. (2004) Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. J Alzheimer Dis 6, 291-301. Cerca con Google

179. Howell G. A., Welch M. G., Frederickson C. J. (1984) Stimulation-induced uptake and release of zinc in hippocampal slices. Nature 308, 736-738. Cerca con Google

180. Hsia A. Y., Masliah E., McConlogue L., Yu G. Q., Tatsuno G., Hu K., Kholodenko D., Malenka R. C., Nicoll R. A. & Mucke L. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96, 3228-3233. Cerca con Google

181. Huang T. H. J., Yang D. S., Plaskos N. P., Go S., Yip C. M., Fraser P. E., Chakrabaetty A. (2000) Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. J Mol Biol 297, 73-87. Cerca con Google

182. Huang X., Atwood C. S., Moir R. D., Hartshorn M. A., Tanzi R. E., Bush A. I. (2004) Trace elements contamination initiates the ap-parent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Abeta peptides. J Biol Inorg Chem 9, 954-60. Cerca con Google

183. Huang X., Cuajungco M. P., Atwood C. S., Hartshorn M. A., Tyndall J. D., Hanson G. R., Stokes K. C., Leopold M., Multhaup G. et al. (1999) Cu (II) potentiation of Alzheimer abeta neurotoxicity. Cor-relation with cell-free hydrogen peroxidase production and metal reduction. J Biol Chem 274, 37111-6. Cerca con Google

184. Hyun D. H., Hernandez J. O., Mattson M. P., de Cabo R. (2006) The plasma membrane redox system in aging. Aging Res Rev 5, 209-220. Cerca con Google

185. Iadecola C. (2003) Cerebrovascular effects of amyloid-ß peptides: mechanisms and implications for Alzheimer’s dementia. Cell Mol Neurobiol 23, 681-689. Cerca con Google

186. Iqbal K., Alonso Adel C., Chen S., Chohan M. O., El-Akkad E., Gong C. X., Khatoon S., Li B. et al. (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739, 198-210. Cerca con Google

187. Jacqmin H., Commenges D., Letenneur L., Barberger-Gateau P., Dar-tigues J. F. (1994) Components of drinking water and risk of cognitive impairments in the elderly. Am J Epidemiol 139, 48-57. Cerca con Google

188. Jagannatha Rao K. S., & Valeswara Rao G. (1995) Aluminum leach-ing from utensils- a kinetic study. Int J Food Sci Nutr 46, 31-38. Cerca con Google

189. Jagannatha Rao K. S., Anitha S. & Latha K. S. (2000) Aluminum-induced neurodegeneration in the hippocampus of aged rabbits mimics Alzheimer’s disease. Alz Rep 3, 83-88. Cerca con Google

190. Jagannatha Rao K. S., Rao R. V., Shanmugavelu P. & Menon R. B. (1999) Trace elements in Alzheimer’s disease brain: a new hy-pothesis. Alz Rep 2, 241-246. Cerca con Google

191. Jarret J. T., Berger E. P. & Lansbury P. T. Jr. (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697. Cerca con Google

192. Jarrett J. T. & Lansbury P. T. Jr. (1993) Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73, 1055-1058. Cerca con Google

193. Jiang D., Men L.,Wang J., Zhang Y., Chickenjen S.,Wang Y., Zhou F. (2007) Redox reactions of copper complexes formed with different beta amyloid peptides and their neuropathological relevance. Biochemistry 46, 9270-9282. Cerca con Google

194. Johnson G. V. & Bailey C. D. Tau, where are we now? J Alzheimers Dis 4, 375-98 (2002). Cerca con Google

195. Johnstone E. M., Chaney M. O., Norris F. H., Pascual R., Little S. P. (1991) Conservation of the sequence of the Alzheimer’s disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res Mol Brain Res 10, 299-305. Cerca con Google

196. Kagan B. L., Hirakura Y., Azimov R., Azimova R. & Lin M. C. (2002) The channel hypothesis of Alzheimer’s disease: current status. Peptides 23, 1311-1315. Cerca con Google

197. Kalaria R. N. (1996) Cerebral vessels in ageing and Alzheimer's dis-ease. Pharmacol Ther 72, 193-214. Cerca con Google

198. Kandimalla K. K., Wengenack T. M., Curran G. L., Gilles E. J. Po-duslo J. F. (2005) Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP, PS1) and its im-plications for amyloid plaque formation. J Pharmacol Exp Ther 313, 1370-1378. Cerca con Google

199. Kawahara M. & Kuroda Y. (2000) Molecular mechanism of neurode-generation induced by Alzheimer’s ß-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res Bull 53, 389-397. Cerca con Google

200. Kawahara M. (2005) Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimer Dis 8, 171-82. Cerca con Google

201. Kawahara M., Kato M., Kuroda Y. (2001) Effects of aluminium on the neurotoxicity of primary cultured neurons and on the aggrega-tion of beta-amyloid protein. Brain Res Bull 55, 211-217. Cerca con Google

202. Kawahara M., Muramoto K., Kobayashi K., Mori H., Kuroda Y. (1994) Aluminum promotes the aggregation of Alzheimer’s amyloid beta-protein in vitro. Biochem Biophys Res Comm 198, 531-535. Cerca con Google

203. Kayed R., Head E., Thompson J. L., Mclntire T. M., Milton S. C., Cotman C. W., Glabe C. G. (2003). Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. Cerca con Google

204. Kayed R., Sokolov Y., Edmonds B., McIntire T. M., Milton S. C., Hall J. E. & Glabe C. G. (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279, 46363-46366. Cerca con Google

205. Kelly J. W. (2000) Mechanisms of amyloidogenesis. Nat Struct Biol 7, 824-6. Cerca con Google

206. Kenward A. G., Bartolotti L. J., Burns C. S. (2007) Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein. Biochemistry 46, 4261-4271. Cerca con Google

207. Kerokoski P., Soininenm H., Pirttilam T. (2001) Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality. Neurochem Int 38, 127-134. Cerca con Google

208. Khachaturian Z. S. (1994) Calcium hypothesis of Alzheimer’s disease and brain aging. Ann NY Acad Sci 747, 1-11. Cerca con Google

209. Kirkitadze M. D., Bitan G., Teplow D. B. (2002) Paradigm shifts in Alzheimer’s disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res 69, 567-577. Cerca con Google

210. Kirkitadze M. D., Condron M. M., Teplow D. B. (2001) Identification and characterization of key kinetic intermediates in amyloid ß-protein fibrillogenesis. J Mol Biol 312, 1103-1119. Cerca con Google

211. Kiss T., Gajda-Schrantz K., Zatta P., (2006) The Role of Aluminium in Neurotoxic and Neurodegenerative Processes. In Sigel A. and H. Sigel H. (Eds.) Neurodegenerative Diseases and Metal Ions, Wiley & Sons, Chichester. Cerca con Google

212. Klatzo I., Wisniewski H. M. & Streicher E. (1965) Experimental production of neurofibrillary degeneration. J Neuropath Exp Neurol 24, 187-199. Cerca con Google

213. Klein W. L., Krafft G. A., Finch C. E. (2001) Targeting small Abeta oli-gomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci 24, 219-224. Cerca con Google

214. Kobayashi S., Hirota N., Saito K., Utsuyama M. (1987) Aluminum ac-cumulation in tangle neurons of Alzheimer’s disease with Balint’s syndrome in a long-term aluminum refiner. Acta Neuropathol (Berl) 74, 47-52. Cerca con Google

215. Koldamova R. & Lefterov I. (2007) Role of LXR and ABCA1 in the pathogenesis of Alzheimer's disease-implications for a new therapeutic approach. Curr Alzheimer Res 4, 171-8. Cerca con Google

216. Kremer J. J., Pallitto M. M., Sklansky D. J., Murphy R. M. (2000) Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochem 39, 10309-18. Cerca con Google

217. Kristian T. & Siesjo B. K. (1998) Calcium in ischemic cell death. Stroke 29, 705-718. Cerca con Google

218. Kuhry J. G., Duportail G., Bronner C., Laustriat G. (1985) Plasma membrane fluidity measurements on whole living cells by fluo-rescence anisotropy of trimethylammoniumdiphenylhexatriene. Biochim Biophys Acta 845, 60-67. Cerca con Google

219. LaFerla F. M., Green K. N. & Oddo S. (2007) Intracellular amyloid-ßï€ in Alzheimer's disease. Nat Rev Neurosci 8, 499-509. Cerca con Google

220. Lacor P. N., Buniel M. C., Chang L., Fernandez S. J., Gong Y. , Viola K. L., Lambert M. P., Velasco P. T. et al. (2004) Synaptic target-ing by Alzheimr’s-related amyloid beta oligomers. J Neurosci 24, 10191-200. Cerca con Google

221. LaFerla F. M. (2002) Calcium dyshomeostasis and intracellular sig-naling in Alzheimer’s disease. Nat Rev Neurosci 3, 862-872. Cerca con Google

222. Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatos M., Morgan T. E., Rozovsky I., et al. (1998) Diffusible, nonfibrillar ligands derived from A beta (1-42) are potent central nervous system neurotoxins. Proc Natl Acad Sci U.S.A 95, 6448-6453. Cerca con Google

223. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., Fahrenholz F. (1999) Constitutive and regulated alpha-secreatase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 96, 3922-3927. Cerca con Google

224. Landsberg J. P., McDonald B., Watt F. (1992) Absence of aluminum in neuritic plaque cores in Alzheimer’s disease. Nature 360, 65-68. Cerca con Google

225. Lansbury P. T. Jr. (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci U S A 96, 3342-3344. Cerca con Google

226. Lau T. L., Ambroggio E. E., Tew D. J., Cappai R., Masters C. L. Fide-lio G. D., Barnham K. J., Separovic F. (2006) Amyloid-beta pep-tide disruption of lipid membranes and the effect of metal ions. J Mol Biol 356, 759-770. Cerca con Google

227. Layfield R., Lowe J., Bedford L. (2005) The ubiquitin-proteosome system and neurodegenerative disorders. Essays Biochem 41, 157-71. Cerca con Google

228. Lee J. Y., Cole T. B., Palmiter R. D., Suh S. W., Koh J. Y. (2002) Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci USA 99, 7705-7710. Cerca con Google

229. Leissring M. A., Murphy M. P., Mead T. R., Akbari Y., Sugarman M. C., Jannatipour M., Anliker B., Muller U. et al. (2002) A physio-logical signaling role for gamma-secretase-derived intracellular fragment of APP. Proc Natl Acad Sci USA 99, 4697-4702. Cerca con Google

230. Lentz B. R. (1993) Use of fluorescent probes to monitor molecular or-der and motions within liposome bilayers. Chem Phys Lipids 64, 99-116. Cerca con Google

231. Lesné S., Koh M. T., Kotilinek L., Kayed R., Glabe C. G., Yang A., Gal-lagher M., Ashe K. H. (2006) A specific amyloid-ß protein assem-bly in the brain impairs memory. Nature 440, 352-357. Cerca con Google

232. Leuner K., Hauptmann S., Abdel-Kader R., Scherping I., Keil U., Strosznajder J. B., Eckert A., Muller W. E. (2007) Mitochondrial dysfunction: the first domino in brain aging and Alzheimer’s dis-ease? Antioxid Redox Signal 9, 1659-75. Cerca con Google

233. LeVine H. (1993) Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2 404-410. Cerca con Google

234. Lewis H. D., Beher D., Smith D., Hewson L., Cookson N., Reynolds D. S., Dawson G. R., Jiang M. et al. (2004) Novel aspects of accumulation dynamics and A beta composition in transgenic models of AD. Neurobiol Aging 25, 1175-1185. Cerca con Google

235. Lin H., Bhatia R., Lal R. (2001) Amyloid beta protein forms ion chan-nels: implications for Alzheimer’s disease pathophysiology. FASEB J 15, 2433-2444. Cerca con Google

236. Lindholm D., Wootz H., Korhonen L. (2006) ER stress and neurode-generative diseases. Cell Death Differ 13, 385-392. Cerca con Google

237. Lippa C. F., Nee L. E., Mori H. & St. George-Hyslop P. (1998) Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease. Lancet 352, 1117-1118. Cerca con Google

238. Liu F., Lau B. H., Peng Q., Shah V. (2000) Pycnogenol protects vascu-lar endothelial cells from ß-amyloid-induced injury. Biol Pham Bull 23, 735-737. Cerca con Google

239. Liu G., Huang W., Moir R. D., Vanderburg C. R., Lai B., Peng Z., Tanzi R. E., Rogers J. T., Huang X. (2006) Metal exposure and Alzheimer’s pathogenesis. J Struct Biol 155, 45-51. Cerca con Google

240. Liu S. T., Howlett G., Barrow C. J. (1999) Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer’s disease. Biochemisty 38, 9373-9378. Cerca con Google

241. Liu Y. & Schubert D. (1997) Cytotoxic amyloid peptides inhibit cellu-lar 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J Neu-rochem 69, 2285-2293. Cerca con Google

242. LivaK K. J. & Schmittgen T. D. (2001) Analysis of relative gene ex-pression data using real-time quantitative PCR and the 2-(Delta Delta C(T)). Methods 25, 402-408. Cerca con Google

243. López-Bendito G., Flames N., Ma L., Fouquet C., Di Meglio T., Chedo-tal A., Lavigne M. T., Marin O. (2007) Robo1 and Robo2 cooper-ate to control the guidance of major axonal tracts in the mam-malian forebrain. J Neurosci 27, 3395-407. Cerca con Google

244. Lorenzo A. & Yankner B. A. (1994) ß-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA 91, 12243-12247. Cerca con Google

245. Lovell M. A., Ehmann W. D., Markesbery W. R. (1993) Laser micro-probe analysis of brain aluminum in Alzheimer's disease. Ann Neurol 33, 36-42. Cerca con Google

246. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L. & Markesbery W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 47-52. Cerca con Google

247. Lovestone S. & Reynolds C. H. (1997) The phosphorylation of tau: a critical stage in neurodevelopmental and neurodegenerative processes. Neuroscience 78, 309-324. Cerca con Google

248. Lu D. C., Rabizadeh S., Chandra S., Shayya R. F., Ellerby L. M., Ye X., Salvesen G. S., Koo E. H. & Bredesen D. E. (2000) A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med 6, 397-404. Cerca con Google

249. Lue L. F., Kuo Y. M., Roher A. E., Brachova L., Shen Y., Sue L., Beach T., Kurth J. H., Rydel R. E., Rogers J. (1999) Soluble amy-loid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am J Pathol 155, 853-862. Cerca con Google

250. Lund E. G., Guileyardo J. M., Russell, D. W. (1999) cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeosta-sis in the brain, Proc Natl Acad Sci USA, 16, 7238-7243. Cerca con Google

251. Lustbader J. W., Cirilli M., Lin C., Xu H. W., Takuma K., Wang N., Caspersen C., Chen X. et al. (2004) ABAD directly links Aß to mi-tochondrial toxicity in Alzheimer’s disease. Science 304, 448-452. Cerca con Google

252. Ma J., Yee A., Brewer H. B., Das S., Potter H. (1994) Amyloid-associated proteins a1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer ß-protein into filaments. Nature 372, 92-94. Cerca con Google

253. Maccioni R. B., Munoz J. P., Barbeito L. (2001) The molecular bases of Alzheimer’s disease and other neurodegenerative disorders. Arch Med Res 32, 367-381. Cerca con Google

254. Mackic J. B., Bading J., Ghiso J., Walker L., Wisniewski T., Fragione B., Zlokovic B. V. (2002) Circulating amyloid-beta peptide crosses the blood-barrier in aged monkeys and contributes to Alzheimer’s disease lesions. Vascul Pharmacol 38, 303-313. Cerca con Google

255. Mancuso M., Filosto M., Bosetti F., Ceravolo R., Rocchi A., Tognoni G., Manca M., L., Solaini G., Siciliano G. & Murri L. (2003) De-creased platelet cytocrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp Neurol 182, 421-6. Cerca con Google

256. Manczak M., Anekonda T. S., Henson E., Park B. S., Quinn J. & Reddy P. H. (2006) Mitochondria are a direct site of Aß accumu-lation in Alzheimer’s disease neurons: implication for free radical generation and oxidative damage in disease progression. Human Molecular Genetics. 15, 1437-1449. Cerca con Google

257. Maness L. M., Banks W. A., Podlisny M. B., Selkoe D. J., Kastin A. J. (1994) Passage of human amyloid β-protein 1-40 across the mur-ine blood-brain barrier. Life Sci 21, 1643-1650. Cerca con Google

258. Mantyh P. W., Ghilardi J. R., Rogers S., DeMaster E., Allen C. J., Stimson E. R., Maggio J. E. (1993) Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem 61, 1171-4. Cerca con Google

259. Markesbery W. R., Ehmann W. D., Alauddin M. & Hossain T. I. M. (1984) Brain trace element concentrations in aging. Neurobiol Ag-ing 5, 19-28. Cerca con Google

260. Marlow L., Canet R. M., Haugabook S. J., Hardy J. A., Lahiri D. K., Sambamurti K. (2003) APH1, PEN2, and Nicastrin increase Abeta levels and gamma-secretase activity. Biochem Biophys Res Com-mun 305, 502-9. Cerca con Google

261. Martin B. R. (1986) The chemistry of Al as related to biology and medicine. Clin Chem 32, 1797-1806. Cerca con Google

262. Martin D. & Leonardo M. (1994) Microscopic quantitation of apoptotic index and cell viability using vital and fluorescent dyes. Curr Pro-toc Immunol 1, 3.17.1-3.17.39. Cerca con Google

263. Mattson M. P. & Chan S. L. (2001) Dysregulation of cellular homeostasis in Alzheimer’s disease: bad genes and bad habits. J Mol Neurosci 17, 205-224. Cerca con Google

264. Mattson M. P. & Kroemer G. (2003) Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol Med 9, 196-205. Cerca con Google

265. Mattson M. P. & Magnus T. (2006) Ageing and neuronal vulnerability. Nat Rev Neurosci 7, 278-94. Cerca con Google

266. Mattson M. P. (1994a) Secreted forms of ß-amyloid precursor protein modulate dendrite outgrowth and calcium responses to gluta-mate in cultured embryonic hippocampal neurons. J Neurobiol 25, 439-450. Cerca con Google

267. Mattson M. P. (1994b) Calcium and neurons injury in Alzheimer’s disease. Contributions of ß-amyloid precursor protein misme-tabolism, free radicals, and metabolic compromise. Ann NY Acad Sci 747, 50-76. Cerca con Google

268. Mattson M. P. (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77, 1081-1132. Cerca con Google

269. Mattson M. P. (1998) Modification of ion homeostasis by lipid peroxi-dation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci 21, 53-57. Cerca con Google

270. Mattson M. P. (2004) Pathways towards and away from Alzheimer’s disease. Nature 430, 631-639. Cerca con Google

271. Mattson M. P. (2007) Calcium and neurodegeneration. Aging Cell 6, 337-350. Cerca con Google

272. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I., Ry-del R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the ß-amyloid pre-cursor protein. Neuron 10, 243-254. Cerca con Google

273. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. E. (1992) ß-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12, 376-389. Cerca con Google

274. Mattson M. P., Engle M. G. & Rychlik B. (1991) Effects of elevated in-tracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons. Mol Chem Neuropathol 15, 117-142. Cerca con Google

275. Mayhan W. G. (2001) Regulation of blood-brain barrier permeability. Microcirculation 8, 89-104. Cerca con Google

276. Maynard C. J., Bush A. I., Masters C. L., Cappai R., & Li Q. X. (2005) Metals and amyloid-ß in Alzheimer’s disease. Int J Exp Path 86, 147-159. Cerca con Google

277. McLachlan D. R., Bergeron C., Smith J. E., Boomer D., Rifat S. L. (1996) Risk for neuropathologically confirmed Alzheimer’s dis-ease and residual aluminum in municipal drinking water em-ploying weighted residential histories. Neurology 46, 401-405. Cerca con Google

278. McLean C. A., Cherny R. A., Fraser F. W., Fuller S. J., Smith M. J., Beyreuther K., Bush A. I., & Masters C. L. (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 46, 860-866. Cerca con Google

279. Minopoli G., Stante M., Napolitano F., Telese F., Aloisa L., De Felice M., Di Lauro R., Pacelli R., Brunetti A., Zambrano N., Russo T. (2007) Essential roles for Fe65, Alzheimer amyloid precursor-binding protein, in the cellular response to DNA damage. J Biol Chem 282, 831-5. Cerca con Google

280. Miu A. C. & Benga O. (2006) Aluminum and Alzheimer’s disease: a new look. J Alzheimer Dis 10, 179-201. Cerca con Google

281. Miura T., Suzuki K., Kohata N., Takeuchi H. (2000) Metal binding modes of Alzheimer’s amyloid ß-peptide in insoluble aggregates and soluble complexes. Biochem 39, 7024-7031. Cerca con Google

282. Miyakawa T. (1997) Electron microscopy of amyloid fibrils and mi-crovessel. Ann NY Acad Sci 826, 25-34. Cerca con Google

283. Mocchegiani E., Costarelli L., Giacconi R., Cipriano C., Muti E., Mala-volta M. (2006) Zinc-binding proteins (metallothionein and al-pha-2 macroglobulin) and immunosenescence. Exp Gerontol 41, 1094-107. Cerca con Google

284. Möller H. J. & Graeber M. B. (1998) The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections. Eur Arch Psychiatry Clin Neurosci 248, 111-122. Cerca con Google

285. Monji A., Tashiro K., Yoshida I., Kaname H., Hayashi Y., Matsuda K. & Tashiro N. (1999) Laminin inhibits both Abeta-4o and Abeta-42 fibril formation but does not affect Abeta-40 or Abeta-42-induced cytotoxicity in PC12 cells. Neurosci Lett 266, 85-88. Cerca con Google

286. Monti M., Garolla di Bard B. L., Calloni G., Chiti F., Amoresano A., Ramponi G. & Pucci P. (2004) The regions of the sequence most exposed to the solvent within the amyloidogenic state of a protein initiate the aggregation process. J Mol Biol 336, 253-262. Cerca con Google

287. Moore P. B., Day J. P., Taylor G. A., Ferrier I. N., Fifield L. K. & Ed-wardson J. A. (2000) Absorption of aluminium-26 in Alzheimer’s disease, measured using accelerator mass spectrometry. Dement Geriatr Cogn Disord 11, 66-69. Cerca con Google

288. Moreira P. I., Santos M. S., Moreno A. M., Seica R. & Oliveira C. R. (2003) Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure. Diabetes 52, 1449-56. Cerca con Google

289. Moreira P. I., Santos M. S., Moreno A., Oliveira C. (2001) Amyloid beta-peptide promotes pearmeability transition pore in brain mitochondria. Biosci Rep 21, 789-800. Cerca con Google

290. Morgan D. M., Dong J., Jacob J., Lu K., Apkarian R. P., Thiyagarajan P., Lynn D. G. (2002) Metal switch for amyloid formation: insight into the structure of the nucleus. J Am Chem Soc 124, 12644-12645. Cerca con Google

291. Morris C. M., Candy J. M., Oakley A. E., Taylor G. A., Mountfort S., Bishop H. et al. (1989) Comparison of the regional distribution of transferring receptors and aluminum in the forebrain of chronic renal dialysis patient. J Neurol Sci 94, 295-306. Cerca con Google

292. Mossman T. (1983) Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J Immunol Meth 65, 55-63. Cerca con Google

293. Mudher A. & Lovestone S. (2002) Alzheimer’s disease-do tauists and baptists finally shake hands? Trends Neurosci 25, 22-26. Cerca con Google

294. Muller W. E., Kirsch C., Eckert G. P. (2001) Membrane-disordering ef-fects of beta-amyloid peptides. Biochem Soc Trans 29, 617-623. Cerca con Google

295. Munoz D. G. (1998) Is exposure of aluminum a risk factor for the de-velopment of Alzheimer’s disease?. Arch Neurol 55, 737-739. Cerca con Google

296. Murphy R. M. (2007) Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins. Biochim Biophys Acta 1768, 1923-34. Cerca con Google

297. Musial A., Bajda M., Malawska B. (2007) Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Curr Med Chem 14, 2654-79. Cerca con Google

298. Nagy Z., Esiri M. M., Jobst K. A., Morris J. H., King E. M., McDonald B., Litchfield S., Smith A., Barnetson L., Smith A. D. (1995) Rela-tive roles of plaques and tangles in the dementia of Alzheimer’s disease: correlations using three sets of neurological criteria. Dementia 6, 21-31. Cerca con Google

299. Naslund J., Haroutunian V., Mohs R., Davis K. L., Davies P., Green-gard P., Buxbaum J. D. (2000) Correlation between elevated lev-els of amyloid ß-peptide in the brain and cognitive decline Proc Natl Acad Sci USA 101, 16180-16185. Cerca con Google

300. Necula M., Kayed R., Milton S. and Glabe C. (2007) Small molecule inhibitors of aggregation indicate that amyloid ß oligomerization and fibrillization pathways are indipendent and distinct. J Biol Chem 282, 10311-10324. Cerca con Google

301. Nemeroff C. B., Luttinger D., Hernandez D. E., Mailman R. B., Mason G. A., Davis S. D., Widerlov, E., Frye G. D., Kilts C. A., Beaumont K., Breese G. R., Prange A. J. (1983) Interaction of neurotensin with brain dopamine systems: biochemical and behavioral stud-ies. J Pharmacol Exp Ther 225, 337-345. Cerca con Google

302. Neumann S., Schobel S., Jager S., Trautwein A., Haass C., Pietrzik C. U., Lichtenthaler S. F. (2006) Amyloid precursor-like protein 1 influences endocytosis and proteolytic processing of the amyloid precursor protein. J Biol Chem 281,7583-94. Cerca con Google

303. Nicholls D. G. (1978) Calcium transport and porton electrochemical potential gradient in mitochondria from guinea-pig cerebral cor-tex and rat heart. Biochem. J. 170, 511-522. Cerca con Google

304. Nicolini M., Zatta P., Corain B. (Eds.) (1991) Aluminum in Chemistry, Biology and Medicine. Raven Press, New York. Cerca con Google

305. Nicolini M., Zatta P., Corain B. (Guest Eds.) (1994) Aluminum in Chemistry, Biology and Medicine. Life Chem Rep 11, 1-267 (spe-cial issue). Cerca con Google

306. Nunan J. & Small D. H. (2000) Regulation of APP cleavage by alpha-, beta-, and gamma-secretase. FEBS Lett 483, 6-10. Cerca con Google

307. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E. K., Jones P. K., Ghanbari H. et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60, 759-67. Cerca con Google

308. Nunomura A., Perry G., Pappolla M. A., Wade R., Hirai K., Chiba S., Smith M. A. (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease. J Neurosci 19, 1959-64. Cerca con Google

309. Oddo S., Billings L., Kesslak J. P., Cribbs D. H., LaFerla F. M. (2004) Abeta immunoteraphy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteosome. Neuron 43, 321-332. Cerca con Google

310. Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., Kayed R., Metherate R., Mattson M. P., Akbari Y., LaFerla F. M. (2003) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Aß and synaptic dysfunction. Neuron 39, 409-421. Cerca con Google

311. Oddo S., Caccamo A., Smith I. F., Green K. N., LaFerla F. M. (2006a) A dynamic relationship between intracellular and extracellular pools of Abeta. Am J Pathol 168, 184-194. Cerca con Google

312. Oddo S., Caccamo A., Tran L., Lambert M. P., Glabe C. G., Klein W. L., LaFerla F. M. (2006b) Temporal Profile of amyloid-ßï€ (Aß) oligomerization in an in vivo model of Alzheimer disease. A link between Aß and tau pathology. J Biol Chem 281, 1599-1604. Cerca con Google

313. Oddo S., Vasilevko V., Caccamo A., Kitazawa M., Cribbs D. H., LaFerla F. M. (2006c) Reduction of soluble Abeta and tau, but not Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 281, 39413-23. Cerca con Google

314. Opazo C., Barria M. I., Ruiz F. H., Inestrosa N. C. (2003) Copper re-duction by copper binding proteins and its relation to neurode-generative diseases. Biometals 16, 91-98. Cerca con Google

315. Opazo C., Huang X., Cherny R. A., Moir R. D., Roher A. E., White A. R., Cappai R., Masters C. L. Tanzi R. E., Inestrosa N. C., Bush A. I. (2002) Metalloenzyme-like activity of Alzheimer’s disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, choles-terol, and biological reducing agents to neurotoxic H(2)O(2). J Biol Chem 277, 40302-8. Cerca con Google

316. Oteiza P. I. (1994) A mechanism for the stimulatory effect of alumi-num on iron-induced lipid peroxidation. Arch Biochem Biophys 308, 374-9. Cerca con Google

317. Pappolla M. A., Chyan Y. J., Omar R. A., Hsiao K., Perry G., Smith M. A, Bozner P. (1998) Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer’s disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 152, 871-877. Cerca con Google

318. Paris D., Ait-Ghezala G., Mathura V. S., Patel N., Quadros A., Laporte V., Mullan M. (2005) Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cells. Brain Res Mol Brain Res 136, 212-30. Cerca con Google

319. Paris D., Patel N., DelleDonne A., Quadros A., Smeed R., Mullan M. (2004a) Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 366, 80-85. Cerca con Google

320. Paris D., Townsend A., Quadros J., Humphrey J., Sun J., Brem S., Wotoczek-Obadia M Cerca con Google

Download statistics

Solo per lo Staff dell Archivio: Modifica questo record